Headlands Technologies LLC Makes New $359,000 Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Headlands Technologies LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 15,463 shares of the company’s stock, valued at approximately $359,000.

A number of other institutional investors also recently modified their holdings of the business. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health in the 4th quarter valued at approximately $26,000. UMB Bank n.a. grew its position in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after purchasing an additional 1,005 shares during the period. Quarry LP lifted its holdings in Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after purchasing an additional 2,628 shares in the last quarter. Finally, Blue Trust Inc. boosted its stake in Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after purchasing an additional 681 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.64% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on OPCH shares. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Barrington Research raised their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. UBS Group assumed coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Finally, Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Trading Up 0.4 %

NASDAQ OPCH opened at $34.94 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock’s 50-day simple moving average is $32.90 and its two-hundred day simple moving average is $28.51. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a market capitalization of $5.74 billion, a price-to-earnings ratio of 29.36, a PEG ratio of 2.30 and a beta of 1.07.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.